Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors.
Invest New Drugs
; 35(6): 766-772, 2017 12.
Article
in En
| MEDLINE
| ID: mdl-28317088
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Signal Transduction
/
Antineoplastic Combined Chemotherapy Protocols
/
Smoothened Receptor
/
Neoplasms
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2017
Document type:
Article
Affiliation country:
Suiza
Country of publication:
Estados Unidos